Cargando…
The Machine-Learning-Mediated Interface of Microbiome and Genetic Risk Stratification in Neuroblastoma Reveals Molecular Pathways Related to Patient Survival
SIMPLE SUMMARY: Neuroblastoma is a highly heterogeneous malignancy with a wide range of outcomes from spontaneous regression to fatal chemoresistant disease, as currently treated according to the risk stratification of the Children’s Oncology Group (COG), resulting in some high COG risk patients rec...
Autores principales: | Li, Xin, Wang, Xiaoqi, Huang, Ruihao, Stucky, Andres, Chen, Xuelian, Sun, Lan, Wen, Qin, Zeng, Yunjing, Fletcher, Hansel, Wang, Charles, Xu, Yi, Cao, Huynh, Sun, Fengzhu, Li, Shengwen Calvin, Zhang, Xi, Zhong, Jiang F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220810/ https://www.ncbi.nlm.nih.gov/pubmed/35740540 http://dx.doi.org/10.3390/cancers14122874 |
Ejemplares similares
-
RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression
Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for
Pediatric Neuroblastoma
por: Sun, Lan, et al.
Publicado: (2023) -
BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study
por: Li, Xiaoqing, et al.
Publicado: (2021) -
Reply to Schramm, L. Comment on “Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364”
por: Li, Xiaoqing, et al.
Publicado: (2022) -
Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
por: Zeng, Yunjing, et al.
Publicado: (2018) -
Corrigendum to: Microfluidic enrichment of plasma cells improves treatment of multiple myeloma
por: Zeng, Yunjing, et al.
Publicado: (2021)